Figure 1.
IFN-γ, CXCL9, CXCL10, and GzmB are highly expressed in the skin lesion, and plasma of vitiligo patients compare to healthy controls. (A) Cytokine panel expression of the paired lesion and non-lesion skin blister interstitial fluid and plasma analyte in vitiligo patients and healthy controls. (B) Relative fold change cytokine panel in skin blisters interstitial fluid analyte in the lesion, and non-lesion skin of vitiligo patients compared to healthy controls. (C) Relative fold change of cytokine panel in plasma analyte of vitiligo patients compared to healthy controls. (V, Vitiligo; L, lesion; NL, non-lesion; *p < 0.05, **p < 0.01, ***p < 0.001; ns, non-significant).